Clinical Trials for Theradex

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Theradex

Clinical Trials (4)

NCT07033598
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
PHASE2Not yet recruiting
66 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
1 condition3 sponsors0 locations
NCT05280314
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
PHASE2Recruiting
60 participants
Started: Dec 21, 2023 · Completed: Jan 31, 2027
2 conditions4 sponsors15 locations
NCT05732103
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
PHASE1/PHASE2Recruiting
225 participants
Started: Apr 25, 2023 · Completed: Feb 28, 2029
2 conditions2 sponsors6 locations
NCT05077709
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
PHASE2Active, not recruiting
63 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2024
3 conditions5 sponsors21 locations